Reuters: Bill Smead on Berkshire’s Investment in Teva
Berkshire buys Teva, feels IBM blues as Apple becomes top investment By Jonathan Stempel For more information go to www.reuters.com. Stocks mentioned: AAPL, AMZN, BRK, IBM, JPM, TEVA, WFC The information contained in this article represents Smead Capital Management’s opinions, and should not be construed
February 14, 2018
